IBI Israel Biomedical Innovations Ltd.

Developer of minimally invasive devices for gynecology and urology.

Medical Devices
Acquired
Caesarea, Israel Founded 2004
Website ↗
Last updated 2026-08-18
Total raised
Stage
Founded
2004
Headcount
HQ
Caesarea, Israel
Sector
Medical Devices

About

IBI Israel Biomedical Innovations (formerly Endogun Medical Systems) develops minimally invasive devices for gynecology and urology. Its primary product, EndoFast Reliant, is a surgical soft tissue fastener for pelvic organ prolapse, which has received FDA approval and CE-Marked. The company also has a joint development agreement with Cook Urological for a bladder fixation device. In August 2011, IBI merged with Allium Medical and now operates as a group company of Allium.

Funding history · 1 round · — total

2011-07
Undisclosed Round Undisclosed
★ Pontifax★ Fund Management Services (2007) Ltd.

Sectors & technology

Primary sector
Medical Devices
Target customers
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

WebsiteEndogun.com

Identifiers & details

Founded2004

Acquisitions & public offerings

Acquired by 2011-08